Change in the amount of body fat and IL-6 levels is related to altered insulin sensitivity in type 1 diabetes patients with or without diabetic nephropathy

Hormone and Metabolic Research

Volumn 43, Issue 3, 2011, Pages 209-215

  Svensson, M K ^a   Eriksson, J W ^a,b  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^b ASTRAZENECA R AND D   (Sweden)

Author keywords

cytokines; diabetic nephropathy; glucose metabolism; hormones; insulin sensitivity; type 1 diabetes

Indexed keywords

ADIPONECTIN; ANGIOTENSIN 2 RECEPTOR ANTAGONIST; C REACTIVE PROTEIN; EDETATE CHROMIUM CR 51; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN ASPART; INSULIN GLARGINE; INSULIN LISPRO; INSULIN ZINC SUSPENSION; INTERLEUKIN 6; ISOPHANE INSULIN; LEPTIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; NEUTRAL INSULIN; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; BODY COMPOSITION; BODY FAT; BODY SURFACE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTINUOUS INFUSION; DIABETIC NEPHROPATHY; DIASTOLIC BLOOD PRESSURE; FEMALE; FOLLOW UP; GLOMERULUS FILTRATION RATE; GLUCOSE CLAMP TECHNIQUE; HUMAN; HYPERINSULINEMIA; INSULIN CLEARANCE; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN SENSITIVITY; LEAN BODY WEIGHT; MALE; METABOLIC CLEARANCE RATE; PRIORITY JOURNAL; PROSPECTIVE STUDY; STEADY STATE; SYSTOLIC BLOOD PRESSURE; TREATMENT OUTCOME; TRIACYLGLYCEROL BLOOD LEVEL;

ADIPOSE TISSUE; ADULT; DIABETES MELLITUS, TYPE 1; DIABETIC NEPHROPATHIES; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; INSULIN; INTERLEUKIN-6; MALE; MIDDLE AGED; PROSPECTIVE STUDIES;

EID: 79952485471     PISSN: 00185043     EISSN: 14394286     Source Type: Journal    
DOI: 10.1055/s-0031-1271622     Document Type: Article

References (33)

1. Mogensen CE, Christensen CK, Vittinghus E. The stages in diabetic renal disease. With emphasis on the stage of incipient diabetic nephropathy. Diabetes 1983 32 64-78 (Pubitemid 13099685)
2. Yip J, Mattock MB, Morocutti A, Sethi M, Trevisan R, Viberti G. Insulin resistance in insulin-dependent diabetic patients with microalbuminuria. Lancet 1993 342 883-887 (Pubitemid 23291590)
3. Yudkin JS, Forrest RD, Jackson CA. Microalbuminuria as predictor of vascular disease in non-diabetic subjects. Islington Diabetes Survey. Lancet 1988 2 530-533
4. Mykkanen L, Zaccaro DJ, Wagenknecht LE, Robbins DC, Gabriel M, Haffner SM. Microalbuminuria is associated with insulin resistance in nondiabetic subjects: the insulin resistance atherosclerosis study. Diabetes 1998 47 793-800 (Pubitemid 28201810)
5. DeFronzo RA, Alvestrand A. Glucose intolerance in uremia: site and mechanism. Am J Clin Nutr 1980 33 1438-1445 (Pubitemid 10013685)
6. DeFronzo RA, Alvestrand A, Smith D, Hendler R, Hendler E, Wahren J. Insulin resistance in uremia. J Clin Invest 1981 67 563-568 (Pubitemid 11141740)
7. Eidemak I, Feldt-Rasmussen B, Kanstrup IL, Nielsen SL, Schmitz O, Strandgaard S. Insulin resistance and hyperinsulinaemia in mild to moderate progressive chronic renal failure and its association with aerobic work capacity. Diabetologia 1995 38 565-572
8. Fliser D, Pacini G, Engelleiter R, Kautzky-Willer A, Prager R, Franek E, Ritz E. Insulin resistance and hyperinsulinemia are already present in patients with incipient renal disease. Kidney Int 1998 53 1343-1347 (Pubitemid 28316896)
9. Svensson M, Yu ZW, Eriksson JW. A small reduction in glomerular filtration is accompanied by insulin resistance in type I diabetes patients with diabetic nephrophathy. Eur J Clin Invest 2002 32 100-109 (Pubitemid 36232730)
10. Becker B, Kronenberg F, Kielstein JT, Haller H, Morath C, Ritz E, Fliser D. Renal insulin resistance syndrome, adiponectin and cardiovascular events in patients with kidney disease: the mild and moderate kidney disease study. J Am Soc Nephrol 2005 16 1091-1098 (Pubitemid 41710320)
11. Svensson M, Eriksson JW. Insulin resistance in diabetic nephropathy - cause or consequence? Diabetes Metab Res Rev 2006 22 401-410 (Pubitemid 44446436)
12. Cooper-DeHoff RM, Pacanowski MA, Pepine CJ. Cardiovascular therapies and associated glucose homeostasis: implications across the dysglycemia continuum. J Am Coll Cardiol 2009 53 S28-S34
13. Goicoechea M, de Vinuesa SG, Lahera V, Cachofeiro V, Gomez-Campdera F, Vega A, Abad S, Luno J. Effects of atorvastatin on inflammatory and fibrinolytic parameters in patients with chronic kidney disease. J Am Soc Nephrol 2006 17 S231-S235 (Pubitemid 44865254)
14. Biesenbach G, Raml A, Schmekal B, Eichbauer-Sturm G. Decreased insulin requirement in relation to GFR in nephropathic Type 1 and insulin-treated Type 2 diabetic patients. Diabet Med 2003 20 642-645 (Pubitemid 36966558)
15. Svensson M, Eriksson JW. No direct link between albumin excretion rate and insulin resistance - a study in type 1 diabetes patients with mild nephropathy. Horm Metab Res 2002 34 254-259 (Pubitemid 34666589)
16. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 1997 20 1183-1197
17. Granerus G, Aurell M. Reference values for 51Cr-EDTA clearance as a measure of glomerular filtration rate. Scand J Clin Lab Invest 1981 41 611-616 (Pubitemid 12252461)
18. DeFronzo RA, Tobin JD, Andres R. Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol 1979 237 E214-E223 (Pubitemid 9249478)
19. DeFronzo RA, Ferrannini E, Sato Y, Felig P, Wahren J. Synergistic interaction between exercise and insulin on peripheral glucose uptake. J Clin Invest 1981 68 1468-1474 (Pubitemid 12194401)
20. Bokemark L, Froden A, Attvall S, Wikstrand J, Fagerberg B. The euglycemic hyperinsulinemic clamp examination: variability and reproducibility. Scand J Clin Lab Invest 2000 60 27-36 (Pubitemid 30167642)
21. Eriksson JW, Jansson PA, Foley K, Lithell H. Insulin sensitivity following treatment with the alpha 1-blocker bunazosin retard and the beta 1-blocker atenolol in hypertensive non-insulin-dependent diabetes mellitus patients. J Hypertens 1996 14 1469-1475
22. Ahmad J, Siddiqui MA, Ahmad H. Effective postponement of diabetic nephropathy with enalapril in normotensive type 2 diabetic patients with microalbuminuria. Diabetes Care 1997 20 1576-1581 (Pubitemid 27415037)
23. Lender D, Arauz-Pacheco C, Adams-Huet B, Raskin P. Essential hypertension is associated with decreased insulin clearance and insulin resistance. Hypertension 1997 29 111-114 (Pubitemid 27078350)
24. Ferrannini E, Wahren J, Faber OK, Felig P, Binder C, DeFronzo RA. Splanchnic and renal metabolism of insulin in human subjects: a dose-response study. Am J Physiol 1983 244 E517-E527 (Pubitemid 13067061)
25. Lukaski HC, Bolonchuk WW, Hall CB, Siders WA. Validation of tetrapolar bioelectrical impedance method to assess human body composition. J Appl Physiol 1986 60 1327-1332 (Pubitemid 16028434)
26. Vareesangthip K, Tong P, Wilkinson R, Thomas TH. Insulin resistance in adult polycystic kidney disease. Kidney Int 1997 52 503-508 (Pubitemid 27359596)
27. Nerpin E, Riserus U, Ingelsson E, Sundstrom J, Jobs M, Larsson A, Basu S, Arnlov J. Insulin sensitivity measured with euglycemic clamp is independently associated with glomerular filtration rate in a community-based cohort. Diabetes Care 2008 31 1550-1555
28. Robertson L, Waugh N, Robertson A. Protein restriction for diabetic renal disease. Cochrane Database Syst Rev 2007 CD002181
29. Trirogoff ML, Shintani A, Himmelfarb J, Ikizler TA. Body mass index and fat mass are the primary correlates of insulin resistance in nondiabetic stage 3-4 chronic kidney disease patients. Am J Clin Nutr 2007 86 1642-1648 (Pubitemid 350232178)
30. Hotamisligil GS, Arner P, Caro JF, Atkinson RL, Spiegelman BM. Increased adipose tissue expression of tumor necrosis factor-alpha in human obesity and insulin resistance. J Clin Invest 1995 95 2409-2415
31. Natali A, Toschi E, Baldeweg S, Ciociaro D, Favilla S, Sacca L, Ferrannini E. Clustering of insulin resistance with vascular dysfunction and low-grade inflammation in type 2 diabetes. Diabetes 2006 55 1133-1140 (Pubitemid 44100192)
32. Cartier A, Lemieux I, Almeras N, Tremblay A, Bergeron J, Despres JP. Visceral obesity and plasma glucose-insulin homeostasis: contributions of interleukin-6 and tumor necrosis factor-alpha in men. J Clin Endocrinol Metab 2008 93 1931-1938 (Pubitemid 351656540)
33. Astrup AS, Tarnow L, Pietraszek L, Schalkwijk CG, Stehouwer CD, Parving HH, Rossing P. Markers of endothelial dysfunction and inflammation in type 1 diabetic patients with or without diabetic nephropathy followed for 10 years: association with mortality and decline of glomerular filtration rate. Diabetes Care 2008 31 1170-1176